Minne HW - Search Results

1

Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass.

Minne HW, Pfeilschifter J, Scharla S, Mutschelknauss S, Schwarz A, Krempien B, Ziegler R. Minne HW, et al. Endocrinology. 1984 Jul;115(1):50-4. doi: 10.1210/endo-115-1-50. Endocrinology. 1984. PMID: 6547388

2

Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.

Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Pfeifer M, et al. Among authors: minne hw. J Clin Endocrinol Metab. 2001 Apr;86(4):1633-7. doi: 10.1210/jcem.86.4.7393. J Clin Endocrinol Metab. 2001. PMID: 11297596 Clinical Trial.

3

Comparative bone analysis via inflammation-mediated osteopenia (IMO) in the rat.

Bauss F, Minne HW, Sterz H, Weng U, Wesch H, Ziegler R. Bauss F, et al. Among authors: minne hw. Calcif Tissue Int. 1985 Sep;37(5):539-46. doi: 10.1007/BF02557838. Calcif Tissue Int. 1985. PMID: 3933793

4

Inflammation-mediated osteopenia in the rat: the effects of artificial granuloma and sham operation on cortical and trabecular bone.

Pfeilschifter J, Minne HW, Enzmann E, Krempien B, Ziegler R. Pfeilschifter J, et al. Among authors: minne hw. Bone. 1985;6(6):461-5. doi: 10.1016/8756-3282(85)90225-x. Bone. 1985. PMID: 4096880

5

Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis).

Scharla SH, Minne HW, Lempert UG, Leidig G, Hauber M, Raedsch R, Ziegler R. Scharla SH, et al. Among authors: minne hw. Exp Clin Endocrinol. 1994;102(1):44-9. doi: 10.1055/s-0029-1211264. Exp Clin Endocrinol. 1994. PMID: 8005208

6

Inflammation-mediated osteopenia (IMO) during acute inflammation in rats is due to a transient inhibition of bone formation.

Pfeilschifter J, Wüster C, Vogel M, Enderes B, Ziegler R, Minne HW. Pfeilschifter J, et al. Among authors: minne hw. Calcif Tissue Int. 1987 Dec;41(6):321-5. doi: 10.1007/BF02556670. Calcif Tissue Int. 1987. PMID: 3124941

7

1,25-Dihydroxyvitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO).

Lempert UG, Minne HW, Albrecht B, Scharla SH, Matthes F, Ziegler R. Lempert UG, et al. Among authors: minne hw. Bone Miner. 1989 Sep;7(2):149-58. doi: 10.1016/0169-6009(89)90072-x. Bone Miner. 1989. PMID: 2804450

8

Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3.

Scharla SH, Minne HW, Waibel-Treber S, Schaible A, Lempert UG, Wüster C, Leyendecker G, Ziegler R. Scharla SH, et al. Among authors: minne hw. J Clin Endocrinol Metab. 1990 Apr;70(4):1055-61. doi: 10.1210/jcem-70-4-1055. J Clin Endocrinol Metab. 1990. PMID: 2138629

9

Effects of endogenous and exogenous calcitonin on inflammation-mediated osteopenia in the rat.

Wüster C, Ding G, Minne HW, Ziegler R. Wüster C, et al. Among authors: minne hw. Horm Res. 1992;37(3):119-23. doi: 10.1159/000182294. Horm Res. 1992. PMID: 1478626

10

Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia.

Hadjidakis D, Lempert UG, Minne HW, Ziegler R. Hadjidakis D, et al. Among authors: minne hw. Horm Metab Res. 1993 Feb;25(2):77-81. doi: 10.1055/s-2007-1002047. Horm Metab Res. 1993. PMID: 8458612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results